Arginine dependency is a therapeutically exploitable vulnerability in chronic myeloid leukaemic stem cells.
暂无分享,去创建一个
M. Copland | G. Helgason | M. Scott | P. Cheng | D. Sumpton | E. Kalkman | S. Tardito | Zuzana Brabcová | F. Mussai | Angela Ianniciello | E. Shokry | J. Vande Voorde | K. Rattigan | B. Prasad | Martha M. Zarou | Daniele Sarnello | Désirée Zerbst | Karen M. Dunn
[1] D. Vetrie,et al. ULK1 inhibition promotes oxidative stress–induced differentiation and sensitizes leukemic stem cells to targeted therapy , 2021, Science Translational Medicine.
[2] S. Morrison,et al. Aspartate availability limits hematopoietic stem cell function during hematopoietic regeneration. , 2021, Cell stem cell.
[3] P. Vyas,et al. Chromatin accessibility governs the differential response of cancer and T cells to arginine starvation , 2021, Cell reports.
[4] Changneng Ke,et al. Arginine metabolism and deprivation in cancer therapy. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[5] C. Craddock,et al. Targeting the arginine metabolic brake enhances immunotherapy for leukaemia , 2019, International journal of cancer.
[6] Gabriela Kalna,et al. Improving the metabolic fidelity of cancer models with a physiological cell culture medium , 2019, Science Advances.
[7] Dustin E. Schones,et al. Arginine starvation kills tumor cells through aspartate exhaustion and mitochondrial dysfunction , 2018, Communications Biology.
[8] M. Blades,et al. Sensitivity of Colorectal Cancer to Arginine Deprivation Therapy is Shaped by Differential Expression of Urea Cycle Enzymes , 2018, Scientific Reports.
[9] M. Snuderl,et al. Aspartate is a limiting metabolite for cancer cell proliferation under hypoxia and in tumors , 2018, Nature Cell Biology.
[10] L. di Lisio,et al. Glutaminolysis is a metabolic dependency in FLT3ITD acute myeloid leukemia unmasked by FLT3 tyrosine kinase inhibition. , 2018, Blood.
[11] S. Fröhling,et al. BCAT1 restricts αKG levels in AML stem cells leading to IDHmut-like DNA hypermethylation , 2017, Nature.
[12] Eyal Gottlieb,et al. Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemic stem cells , 2017, Nature Medicine.
[13] M. Carroll,et al. Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism. , 2017, Cancer discovery.
[14] Jason M. Held,et al. Arginine Deprivation Inhibits the Warburg Effect and Upregulates Glutamine Anaplerosis and Serine Biosynthesis in ASS1-Deficient Cancers , 2017, Cell reports.
[15] C. Eaves,et al. Analysis of parameters that affect human hematopoietic cell outputs in mutant c-kit-immunodeficient mice , 2017, Experimental hematology.
[16] D. Vetrie,et al. Epigenetic Reprogramming Sensitizes CML Stem Cells to Combined EZH2 and Tyrosine Kinase Inhibition. , 2016, Cancer discovery.
[17] G. Georgiou,et al. Systemic depletion of serum l-Cyst(e)ine with an engineered human enzyme induces production of reactive oxygen species and suppresses tumor growth in mice , 2016, Nature medicine.
[18] Karen Dunn,et al. Dual targeting of p53 and c-Myc selectively eliminates leukaemic stem cells , 2016, Nature.
[19] K. Pienta,et al. Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation , 2016, Journal of visualized experiments : JoVE.
[20] Ole Winther,et al. BloodSpot: a database of gene expression profiles and transcriptional programs for healthy and malignant haematopoiesis , 2015, Nucleic Acids Res..
[21] E. Ruppin,et al. Diversion of aspartate in ASS1-deficient tumors fosters de novo pyrimidine synthesis , 2015, Nature.
[22] P. Kearns,et al. Arginine dependence of acute myeloid leukemia blast proliferation: a novel therapeutic target. , 2015, Blood.
[23] Frank Y. S. Chuang,et al. Arginine starvation-associated atypical cellular death involves mitochondrial dysfunction, nuclear DNA leakage, and chromatin autophagy , 2014, Proceedings of the National Academy of Sciences.
[24] Curt I Civin,et al. Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile. , 2013, Blood.
[25] Richard J. Jones,et al. Genome-wide comparison of the transcriptomes of highly enriched normal and chronic myeloid leukemia stem and progenitor cell populations , 2013, Oncotarget.
[26] S. Fan,et al. A phase 1 dose-escalating study of pegylated recombinant human arginase 1 (Peg-rhArg1) in patients with advanced hepatocellular carcinoma , 2012, Investigational New Drugs.
[27] A. Hamilton,et al. Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival. , 2012, Blood.
[28] G. Giaever,et al. Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia. , 2011, Cancer cell.
[29] B. Druker,et al. Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity. , 2011, The Journal of clinical investigation.
[30] D. Gisselsson,et al. Modeling the human 8p11-myeloproliferative syndrome in immunodeficient mice. , 2010, Blood.
[31] S. Shurtleff,et al. Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] Francisco Cervantes,et al. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. , 2006, The New England journal of medicine.
[33] M Giehl,et al. Gene expression profiling of CD34+ cells identifies a molecular signature of chronic myeloid leukemia blast crisis , 2006, Leukemia.
[34] H. Kantarjian,et al. The natural history of chronic myelogenous leukemia in the interferon era. , 1995, Seminars in hematology.
[35] Susan M. Watanabe,et al. An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity , 1984, Cell.
[36] J. Stephenson,et al. Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22 , 1984, Cell.
[37] J. Rowley. A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining , 1973, Nature.
[38] M. Baccarani,et al. European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia. , 2016, Leukemia.
[39] C. Waller. Imatinib mesylate. , 2010, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[40] Y. Leung,et al. Pegylated recombinant human arginase (rhArg-peg5,000mw) inhibits the in vitro and in vivo proliferation of human hepatocellular carcinoma through arginine depletion. , 2007, Cancer research.
[41] the original work is properly cited. , 2022 .